Project Grant R21NS134813
Award Date
9/22/23
Completion Date
8/31/25
Dollars Obligated
$414K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Kingston, RI 02881, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $502,929 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Feinstein Institutes for Medical Research. The objective of this 4-year grant, with an award date of September 1, 2024, is to evaluate the impact of the Heat Vulnerability Index (HVI) on stroke functional outcomes in individuals with Alzheimer's disease and related dementias. The HVI, developed...
This $624,583 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of Washington to identify potential therapeutic targets for preventing ischemic stroke. The project will leverage existing plasma samples, genomic data, and electronic medical records from the Heart and Vascular Health Study to evaluate...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $423,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Augusta University Research Institute, Inc. The objective is to develop and evaluate engineered exosomes carrying neuron-targeting peptides and a therapeutic protein (neuroglobin) for treating ischemic stroke. The research will: 1) characterize the engineered exosomes and assess their...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $127,076 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to Brown University. The funding will support the "Research and Clinical Experiences in Neurology, Neurosurgery and Neurosciences (R-CEIN)" program, which aims to foster diversity in the neurosciences. The program will provide undergraduate students from...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,830,581 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to The Johns Hopkins University. The grant supports in-depth characterization of the mechanism of action of a new macrocycle molecule called RAPIREON, which selectively activates the nuclease activity of the IRE1 protein in the unfolded protein response (UPR) pathway....
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of the CCL2/CCR2 signaling pathway in modulating HIV-associated ischemic stroke severity and recovery. The $422,125 award, effective from September 18, 2024 to August 31, 2026, will be conducted by the University of Miami. The research aims to...
This $458,005 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program will fund a research project led by Dr. James Giles at Yale University. The project aims to investigate the cellular pathogenesis of stroke thrombi and how these differences may relate to the etiology of stroke and the clinical response to revascularization...
The National Institute on Aging, part of the Department of Health and Human Services' National Institutes of Health, awarded $3,387,438 under the Aging Research program (CFDA 93.866) to The Ohio State University Office of Sponsored Programs on September 19, 2022. The three-year project grant aims to develop and test a novel neuroprotective agent, TAT-M2NX, to provide both acute and sustained synaptic protection following acute ischemic stroke. The research seeks to characterize the agent's...
The University of Rhode Island (URI) Research Office is receiving a $2,727,001 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The grant will fund research to validate a rabbit model of cerebral palsy-induced pain. Key components include: Determining the face validity of the rabbit hypoxia-ischemia model to assess musculoskeletal, nociplastic, and neuropathic pain phenotypes...
This federal Project Grant award for $853,135 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will fund research at Dignity Health's St. Joseph's Hospital and Medical Center in Phoenix, AZ to study the role of the complement C3A receptor in exacerbating brain injury and functional impairment following ischemic stroke. The research aims to...